GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 142 filers reported holding GOSSAMER BIO INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,588,841 | -58.9% | 309,300 | -57.3% | 0.00% | 0.0% |
| Q1 2022 | $6,291,264 | -23.2% | 724,800 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $8,197,000 | -10.0% | 724,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,111,000 | +54.8% | 724,800 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $5,885,000 | -12.2% | 724,800 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $6,704,000 | -23.5% | 724,800 | -20.0% | 0.00% | 0.0% |
| Q4 2020 | $8,761,000 | -22.1% | 906,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $11,243,000 | -4.5% | 906,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,778,000 | +146.9% | 906,000 | +92.8% | 0.00% | +50.0% |
| Q1 2020 | $4,771,000 | -61.6% | 470,000 | -40.8% | 0.00% | -33.3% |
| Q4 2019 | $12,415,000 | -0.5% | 794,275 | +6.9% | 0.00% | -25.0% |
| Q3 2019 | $12,475,000 | -14.4% | 742,991 | +13.1% | 0.00% | -20.0% |
| Q2 2019 | $14,574,000 | +43.1% | 657,081 | +39.8% | 0.01% | +66.7% |
| Q1 2019 | $10,185,000 | – | 470,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |